Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Maxygen
(NQ:
MAXY
)
2.380
USD
+0.020 (+0.85%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Maxygen
< Previous
1
2
3
4
Next >
Maxygen Reports First Quarter 2013 Financial Results
May 03, 2013
from
Business Wire News Releases
Maxygen Reports Fourth Quarter and Year End 2012 Financial Results
March 12, 2013
from
Business Wire News Releases
Maxygen Announces Tax Treatment of 2012 Cash Distribution
January 29, 2013
from
Business Wire News Releases
Altravax, Inc. Awarded $1.2 Million to Advance Dengue Vaccine and Hepatitis Therapeutic
January 08, 2013
from
Business Wire News Releases
Altravax, Inc. Awarded $3.45 Million in NIH Funds for Vaccines to HIV/AIDS
December 03, 2012
from
Business Wire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
November 12, 2012
from
GlobeNewswire News Releases
Maxygen Announces Third Quarter 2012 Financial Results
November 06, 2012
from
Business Wire News Releases
Maxygen Announces Second Quarter 2012 Financial Results and Business Update
August 07, 2012
from
Business Wire News Releases
Maxygen to Receive $30 Million Payment from Bayer
May 14, 2012
from
Business Wire News Releases
Maxygen Reports First Quarter 2012 Financial Results
May 07, 2012
from
Business Wire News Releases
Maxygen Reports Fourth Quarter and Year End 2011 Financial Results
March 08, 2012
from
Business Wire News Releases
Maxygen Announces $10 Million Stock Repurchase Program
January 10, 2012
from
Business Wire News Releases
Maxygen Announces BARDA Decision Not To Award Contract for Development of MAXY-G34 for Acute Radiation Syndrome
November 09, 2011
from
Business Wire News Releases
Maxygen Reports Third Quarter 2011 Financial Results
November 07, 2011
from
Business Wire News Releases
Maxygen Announces Final Rejection of All Claims of Amgen ‘804 Patent in Inter Partes Reexamination Proceeding
October 10, 2011
from
Business Wire News Releases
Maxygen Announces $10 Million Increase in Stock Repurchase Program
September 08, 2011
from
Business Wire News Releases
Maxygen Reports Second Quarter 2011 Financial Results
August 08, 2011
from
Business Wire News Releases
Maxygen Announces $10 Million Stock Repurchase Program
May 31, 2011
from
Business Wire News Releases
Astellas and Maxygen Announce Completion of Acquisition of Perseid by Astellas
May 16, 2011
from
Business Wire News Releases
Maxygen Reports First Quarter 2011 Financial Results
May 05, 2011
from
Business Wire News Releases
Maxygen Submits Proposal to BARDA for Development of MAXY-G34 for Acute Radiation Syndrome
May 03, 2011
from
Business Wire News Releases
BestOfOTC.com Stocks in Focus at NASDAQ: (AAPL, FEIM, FPFC, INTC, MAXY, NVDA, NYMX, ORCL)
March 21, 2011
from
EmailWire.Com Press Releases
Astellas Exercises Option to Purchase Maxygen’s Interest in Perseid
March 17, 2011
from
Business Wire News Releases
INO, MAXY, GBX, TAT, HRBN: Focus On These Active Stocks Today
March 17, 2011
from
EmailWire.Com Press Releases
Maxygen Reports Fourth Quarter and Year End 2010 Financial Results
March 08, 2011
from
Business Wire News Releases
Maxygen Announces Tax Treatment of 2010 Distributions
February 04, 2011
from
Business Wire News Releases
Maxygen Announces Initiation of Phase I Clinical Trial Under Perseid’s Collaboration with Astellas for CTLA4-Ig Program
January 31, 2011
from
Business Wire News Releases
Maxygen Announces Distributions of Codexis Shares and Cash
November 22, 2010
from
Business Wire News Releases
Maxygen Reports Third Quarter 2010 Financial Results
November 04, 2010
from
Business Wire News Releases
Maxygen Announces Sale of MolecularBreeding™ Directed Evolution Platform Technology to Codexis
October 28, 2010
from
Business Wire News Releases
< Previous
1
2
3
4
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here